-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ECI-001 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ECI-001 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ECI-001 in Breast Cancer Drug Details: ECI-001 is under development for the...
-
Product Insights
Turu
Turu is a Hydro project located in Arunachal Pradesh, India. The project is owned by ECI Engineering & Construction Co Ltd; KVK Energy & Infrastructure Pvt Ltd and is developed by Turu Hydro Energy Pvt Ltd. The project is expected to come online in 2028. Empower your strategies with our Turu report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
ECI Group – Banyan View Apartment Complex – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our ECI Group - Banyan View Apartment Complex - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
ECI Group/ Phoenix Cap – Averly East Village Residential Development – Georgia
Equip yourself with the essential tools needed to make informed and profitable decisions with our ECI Group/ Phoenix Cap - Averly East Village Residential Development - Georgia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
ECI Group/ Mercury Adv – Channel Club II Residential Complex – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our ECI Group/ Mercury Adv - Channel Club II Residential Complex - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
SailPoint Technologies Holdings Inc – Company Profile
SailPoint Technologies Holdings Inc (SailPoint), a subsidiary of Thoma Bravo LP , is an identity governance platform provider. IdentityIQ, an on-premise identity governance platform, allows businesses to monitor users, apps, access, and data across cloud and on-premise applications for risk elimination. Its cloud-based platform IdentityNow unifies the identity management process across on-premise, mobile, and cloud environments while SecurityIQ protects the unstructured data from cyber-attacks. The company’s clients consist of Rockwell Automation, Weight Watchers, Sallie Mae, Allianz, AXA, Western Union, Molina...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ECI-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ECI-001 Drug Details ECI-001 is under development for the treatment of breast cancer. The...
-
Product Insights
Bacteriology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology Rapid Tests & POC comprises rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Chlamydia, H. pylori, Streptococci, and Syphilis. The Bacteriology Rapid Tests & POC pipeline market research report provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Government & Regulation
Singapore Renewable Energy Policy Handbook 2022 Update
Singapore has set a target to achieve 2GW of Solar PV capacity by 2030. The Singapore renewable energy policy handbook offers comprehensive information on major policies governing the renewable energy market in the country. The report also discusses renewable energy targets and plans along with the present policy framework, giving a fair idea of the overall growth potential of the renewable energy industry. Moreover, the report provides major technology-specific policies and incentives provided in the country.
-
Sector Analysis
Singapore Solar Photovoltaic (PV) Market Size and Trends by Installed Capacity, Generation and Technology, Regulations, Power Plants, Key Players and Forecast, 2022-2035
Singapore solar photovoltaic (PV) market cumulative installed capacity was valued at 632.40 MW in 2021. The market is expected to grow at a CAGR of more than 10% during 2021-2035. The Singapore solar photovoltaic (PV) market research report highlights installed capacity and power generation trends from 2010 to 2035 in the country’s solar PV market. A detailed coverage of renewable energy policy framework governing the market is provided in the report. The report also provides company snapshots of some of...